admin @ February 18, 2009 # No Comment Yet
Umbilical cord blood, bone marrow, and circulating blood were once the three primary sources of CD34+ stem cells, but research has revealed an abundant fourth source: the placenta. Banking placenta-derived stem cells can lead to significant potential health benefits.
Since the placenta is up to 15 times richer in CD34+ stem cells than cord blood, banking […]
More on page 165
admin @ January 17, 2009 # No Comment Yet
Cord blood banks have given clients with leukemia reason to be optimistic, as using CD34+ stem cells derived from umbilical cord blood to cure leukemia has proven to be a promising form of treatment. Since the risk of infectious disease transmission is lower for cord blood stem cell transplants compared to bone marrow stem cell […]
More on page 162
admin @ February 21, 2008 # No Comment Yet
Placenta-derived stem cells could one day be used to treat many life-threatening diseases. Cord blood stem cells have already being used to treat over eighty diseases. Cord blood stem cells, in combination with placenta-derived stem cells , are being researched to treat many other life-threatening diseases. Hematopoietic (blood forming) cells and CD34+ cells are […]
More on page 32